etoposide has been researched along with demecolcine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansch, C; Khwaja, TA; Selassie, CD | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Epstein, RJ; Smith, PJ; Watson, JV | 1 |
| Fulka, J; Moor, RM | 1 |
| Aggarwal, BB; Gallati, H; Loetscher, H; Mihalik, R; Penzes, M; Pocsik, E | 1 |
| Sumner, AT | 1 |
| Burns, EM; Christopoulou, L; Corish, P; Tyler-Smith, C | 1 |
| Mahyar-Roemer, M; Roemer, K | 1 |
| Fulka, H; Fulka, J; Loi, P; Nagai, T; Ptak, G | 1 |
| Falck Miniotis, M; Gjörloff Wingren, A; Mukwaya, A | 1 |
1 review(s) available for etoposide and demecolcine
| Article | Year |
|---|---|
Nucleus transfer in mammals: noninvasive approaches for the preparation of cytoplasts.
Topics: Animals; Animals, Domestic; Centrifugation, Density Gradient; Cloning, Organism; Cycloheximide; Cytological Techniques; Demecolcine; Etoposide; Ionomycin; Mammals; Maturation-Promoting Factor; Metaphase; Mice; Micromanipulation; Microscopy, Fluorescence; Microscopy, Polarization; Nocodazole; Nuclear Transfer Techniques; Oocytes; Spindle Apparatus; Sucrose | 2004 |
9 other study(ies) available for etoposide and demecolcine
| Article | Year |
|---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Subpopulation analysis of drug-induced cell-cycle delay in human tumor cells using 90 degrees light scatter.
Topics: Breast Neoplasms; Cell Cycle; Cell Separation; Demecolcine; DNA, Neoplasm; Etoposide; Flow Cytometry; Humans; Light; Microscopy, Fluorescence; Mitosis; Mitotic Index; Scattering, Radiation; Staining and Labeling; Tumor Cells, Cultured; Vincristine | 1988 |
Sister chromatid separation and the metaphase-anaphase transition in mouse oocytes.
Topics: Anaphase; Animals; Cell Nucleus; Chromatids; Chromatin; Demecolcine; Etoposide; Female; Maturation-Promoting Factor; Meiosis; Mesothelin; Metaphase; Mice; Microtubules; Oocytes; Topoisomerase II Inhibitors | 1994 |
Effect of cell cycle on the regulation of the cell surface and secreted forms of type I and type II human tumor necrosis factor receptors.
Topics: Cell Cycle; Demecolcine; DNA; Enzyme Inhibitors; Etoposide; G1 Phase; G2 Phase; HeLa Cells; Humans; Hydroxyurea; Leukemia, Erythroblastic, Acute; Lymphoma, Large B-Cell, Diffuse; Mitosis; Nocodazole; Receptors, Tumor Necrosis Factor; S Phase; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Vinblastine | 1995 |
Induction of diplochromosomes in mammalian cells by inhibitors of topoisomerase II.
Topics: Amsacrine; Animals; CHO Cells; Chromatids; Chromosome Aberrations; Chromosome Segregation; Cricetinae; Demecolcine; DNA Topoisomerases, Type II; Enzyme Inhibitors; Etoposide; Interphase; Metaphase; Mitoxantrone; Nucleic Acid Synthesis Inhibitors; Topoisomerase II Inhibitors | 1998 |
Quantitative measurement of mammalian chromosome mitotic loss rates using the green fluorescent protein.
Topics: Aneuploidy; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Buffers; Caffeine; Cell Fusion; Chromosome Aberrations; Chromosomes, Artificial, Yeast; Demecolcine; Etoposide; Flow Cytometry; Glucose; Green Fluorescent Proteins; HeLa Cells; Humans; In Situ Hybridization, Fluorescence; Indicators and Reagents; Luminescent Proteins; Mammals; Mice; Mitosis; Nocodazole; Phosphodiesterase Inhibitors; Plasmids; Yeasts | 1999 |
p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents.
Topics: Adenocarcinoma; Alleles; Amino Acid Chloromethyl Ketones; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Benzothiazoles; Butyrates; Cisplatin; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Proteinase Inhibitors; Demecolcine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Intracellular Membranes; Membrane Potentials; Mitochondria; Neoplasm Proteins; Recombination, Genetic; Resveratrol; Stilbenes; Thiazoles; Toluene; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
Digital holographic microscopy for non-invasive monitoring of cell cycle arrest in L929 cells.
Topics: Animals; Cell Cycle Checkpoints; Cell Line; Demecolcine; Dose-Response Relationship, Drug; Etoposide; Holography; Mice; Microscopy; Staurosporine | 2014 |